Trial · NCT03045406
Adverse events586
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 586
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Apixaban | 33 | 576 | 38 |
| other | Anaemia | Blood and lymphatic system disorders | Dalteparin | 21 | 579 | 27 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Apixaban | 33 | 576 | 38 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Dalteparin | 24 | 579 | 28 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Apixaban | 23 | 576 | 23 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Dalteparin | 29 | 579 | 36 |
| serious | Anaemia | Blood and lymphatic system disorders | Apixaban | 6 | 576 | 6 |
| serious | Anaemia | Blood and lymphatic system disorders | Dalteparin | 4 | 579 | 5 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | Apixaban | 5 | 576 | 6 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | Dalteparin | 4 | 579 | 4 |
| serious | Anaemia Of Malignant Disease | Blood and lymphatic system disorders | Apixaban | 1 | 576 | 1 |
| serious | Anaemia Of Malignant Disease | Blood and lymphatic system disorders | Dalteparin | 0 | 579 | 0 |
| serious | Bone Marrow Failure | Blood and lymphatic system disorders | Apixaban | 1 | 576 | 1 |
| serious | Bone Marrow Failure | Blood and lymphatic system disorders | Dalteparin | 0 | 579 | 0 |
| serious | Coagulopathy | Blood and lymphatic system disorders | Apixaban | 1 | 576 | 1 |
| serious | Coagulopathy | Blood and lymphatic system disorders | Dalteparin | 0 | 579 | 0 |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | Apixaban | 1 | 576 | 2 |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | Dalteparin | 2 | 579 | 2 |
| serious | Microcytic Anaemia | Blood and lymphatic system disorders | Apixaban | 1 | 576 | 1 |
| serious | Microcytic Anaemia | Blood and lymphatic system disorders | Dalteparin | 0 | 579 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03045406/events